| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | 10%+ Owner | Common Shares | 53,412,414 | $252,106,594 | $4.72 | 30 Sep 2025 | By Apeiron Investment Group Ltd. |
| BIONOMICS LTD/ADR | 10%+ Owner | Ordinary Shares | 183,121,441 | $60,430,076 | $0.3300 | 01 Jul 2024 | By Apeiron Investment Group Ltd. |
| BIONOMICS LTD/ADR | 10%+ Owner | Ordinary Shares | 93,369,060 | $30,811,790 | $0.3300 | 04 Oct 2024 | By Apeiron Presight Capital Fund II, L.P. |
| ATAI Life Sciences N.V. | 10%+ Owner | Common Shares | 1,799,302 | $8,492,705 | $4.72 | 30 Sep 2025 | By Apeiron Presight Capital Fund II, L.P. |
| Alto Neuroscience, Inc. | Other* | Common Stock | 674,658 | 06 Feb 2024 | By Apeiron Presight Capital Fund II, L.P.( | ||
| Alto Neuroscience, Inc. | Other* | Common Stock | 251,881 | 06 Feb 2024 | Direct | ||
| Alto Neuroscience, Inc. | Other* | Series A Preferred Stock | 0 | 06 Feb 2024 | By Apeiron Presight Capital Fund II, L.P. | ||
| Alto Neuroscience, Inc. | Other* | Series A Preferred Stock | 0 | 06 Feb 2024 | Direct | ||
| Alto Neuroscience, Inc. | Other* | Series B Preferred Stock | 0 | 06 Feb 2024 | By Apeiron Presight Capital Fund II, L.P. | ||
| Alto Neuroscience, Inc. | Other* | Warrants to Purchase Series A Preferred Stock | 0 | 06 Feb 2024 | Direct | ||
| ATAI Life Sciences N.V. | 10%+ Owner | Convertible Notes | 0 | 30 Sep 2025 | By Apeiron Investment Group Ltd. | ||
| Sensei Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $0.8500 | 01 Jun 2023 | By Apeiron Investment Group Ltd. | |
| Sensei Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $0.8500 | 01 Jun 2023 | By Presight Sensei Co-Invest Fund, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATAI | ATAI Life Sciences N.V. | 30 Sep 2025 | 2 | $0 | 4 | 10%+ Owner | 02 Oct 2025, 16:18 |
| ATAI | ATAI Life Sciences N.V. | 14 Aug 2025 | 1 | +$19,000,000 | 4 | 10%+ Owner | 18 Aug 2025, 18:00 |
| ATAI | ATAI Life Sciences N.V. | 24 Mar 2025 | 1 | +$2,520,000 | 4 | 10%+ Owner | 24 Mar 2025, 17:00 |
| ATAI | ATAI Life Sciences N.V. | 14 Feb 2025 | 1 | +$22,755,008 | 4 | 10%+ Owner | 19 Feb 2025, 18:00 |
| /report/000095017024113344-apeiron-investment-group-ltd-2024-07-01 | BIONOMICS LTD/ADR | 01 Jul 2024 | 3 | -$82,527 | 4 | 10%+ Owner | 07 Oct 2024, 18:22 |
| /report/000095017024113341-apeiron-investment-group-ltd-2024-07-01 | BIONOMICS LTD/ADR | 01 Jul 2024 | 0 | $0 | 3 | 10%+ Owner | 07 Oct 2024, 18:17 |
| ATAI | ATAI Life Sciences N.V. | 15 Apr 2024 | 2 | $0 | 4 | 10%+ Owner | 17 Apr 2024, 16:15 |
| ANRO | Alto Neuroscience, Inc. | 06 Feb 2024 | 6 | $0 | 4 | Other* | 06 Mar 2024, 09:15 |
| SNSE | Sensei Biotherapeutics, Inc. | 01 Jun 2023 | 2 | -$5,437,824 | 4 | 10%+ Owner | 02 Jun 2023, 17:03 |
| ATAI | ATAI Life Sciences N.V. | 29 Mar 2023 | 1 | +$1,600,443 | 4 | 10%+ Owner | 29 Mar 2023, 16:05 |
| SNSE | Sensei Biotherapeutics, Inc. | 23 Feb 2023 | 2 | +$3,539 | 4 | 10%+ Owner | 27 Feb 2023, 19:10 |
| ANRO | Alto Neuroscience, Inc. | 01 Feb 2023 | 0 | $0 | 3 | 10%+ Owner | 02 Feb 2024, 16:54 |
| SNSE | Sensei Biotherapeutics, Inc. | 14 Jul 2022 | 0 | $0 | 3 | 10%+ Owner | 20 Jul 2022, 09:53 |
| ATAI | ATAI Life Sciences N.V. | 28 Apr 2022 | 2 | +$252,490 | 4 | 10%+ Owner | 02 May 2022, 16:15 |
| ATAI | ATAI Life Sciences N.V. | 26 Apr 2022 | 2 | +$308,567 | 4 | 10%+ Owner | 28 Apr 2022, 16:26 |
| ATAI | ATAI Life Sciences N.V. | 22 Apr 2022 | 2 | +$297,805 | 4 | 10%+ Owner | 26 Apr 2022, 16:15 |
| ATAI | ATAI Life Sciences N.V. | 20 Apr 2022 | 2 | +$684,553 | 4 | 10%+ Owner | 03 May 2022, 16:16 |
| ATAI | ATAI Life Sciences N.V. | 18 Apr 2022 | 2 | +$612,395 | 4 | 10%+ Owner | 20 Apr 2022, 16:30 |
| ATAI | ATAI Life Sciences N.V. | 14 Apr 2022 | 1 | +$25,779 | 4 | 10%+ Owner | 18 Apr 2022, 16:15 |
| ATAI | ATAI Life Sciences N.V. | 12 Apr 2022 | 1 | +$269,560 | 4 | 10%+ Owner | 14 Apr 2022, 16:15 |
| ATAI | ATAI Life Sciences N.V. | 08 Apr 2022 | 2 | +$538,194 | 4 | 10%+ Owner | 12 Apr 2022, 16:30 |
| ATAI | ATAI Life Sciences N.V. | 06 Apr 2022 | 1 | +$959,800 | 4 | 10%+ Owner | 07 Apr 2022, 16:15 |
| ATAI | ATAI Life Sciences N.V. | 22 Jun 2021 | 1 | +$10,500,000 | 4 | 10%+ Owner | 24 Jun 2021, 16:16 |
| ATAI | ATAI Life Sciences N.V. | 17 Jun 2021 | 0 | $0 | 3/A | 10%+ Owner | 25 Aug 2021, 16:00 |